Skip to main content
Log in

Normal thyroxine and elevated thyrotropin concentrations: Evolving hypothyroidism or persistent euthyroidism with reset thyrostat

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Background

The natural course in subjects manifesting normal serum thyroxine (T4), and triiodothyronine (T3), with an elevated thyrotropin (TSH) level demonstrated two distinct outcomes, one progressing to well defined hypothyroidism as expressed by onset of subnormal T4, T3 and a further rise in TSH and the other remaining in the same state. However, thyroid hormone concentrations at the time of diagnosis fail to distinguish between the two groups. Therefore, we examined the influence of alteration in circulating TSH levels on thyroid gland function at the time of diagnosis in subjects with this syndrome to assess the role of pituitary thyroid axis in these different outcomes.

Methods

24 hour 131I thyroidal uptake was determined in 14 men and 3 women manifesting normal T4, T3 and elevated TSH prior to and again after 1) subcutaneous administration of bovine TSH, 10 units daily for 3 days and 2) daily oral administration of L.-triiodothyronine 75 μg for 7 days in a randomized sequence at interval of 4 weeks. Subjects were then followed for up to 16 years to assess the natural course.

Results

Basal 24 hour131I uptake values were with-in the normal range (10–35%) in all subjects and increased on TSH administration and declined following LT3 administration. However, in eight subjects, these responses were markedly lower (< 20%) when compared with the minimum change (50%) noted in normal volunteers. These subjects progressed to manifest hypothyroidism requiring LT4 therapy within two years as reflected by a progressive decrease to subnormal T4 levels with a further rise in serum TSH. The remaining nine subjects, demonstrated normal responses (> 50%) and only one of these became hypothyroid during the follow-up period of 16 years.

Conclusion

All subjects with normal T4 and T3 with elevated TSH do not manifest “subclinical or evolving hypothyroidism”. Two distinct populations seem to exist, one with inhibited pituitary thyroid axis progressing to hypothyroidism or true “subclinical hypothyroidism” at the time of diagnosis and the other with normal pituitary thyroid axis, a state of euthyroidism with “reset thyrostat” at a higher TSH concentration, a state probably persisting for their remaining life span.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Cooper D.S., Halpern R., Wood L.C., Levin A.A., Ridgway E.C. L-Thyroxine therapy in “subclinical hypothyroidism”: A double-blind, placebo-controlled trial. Ann. Intern. Med. 1001: 18, 1984.

    Article  Google Scholar 

  2. Nystrom E., Ca K., Fager G., Wikkelso C, Lunberg P.A., Lindstedt G. A double-blind cross-over 12-month study of L- thyroxine treatment of women with “subclinical” hypothyroidism. Clin. Endocrinol. (Oxf.) 29: 63, 1988.

    Article  CAS  Google Scholar 

  3. Bastenie P.A., Vanhaelst L, Neve P. Coronary artery disease in hypothyroidism: Observation in preclinical myoedema. Lancet 2: 1221, 1967.

    Article  PubMed  CAS  Google Scholar 

  4. Fowler P.B.S., Swale J., Andrews H. Hypercholesterolemia in borderline hypothyroidism: Stage of premyxoedema. Lancet 2: 488, 1970.

    Article  PubMed  CAS  Google Scholar 

  5. Bastenie P.A., Vanhaelst L., Bonnyns L., Neve P., Staquet M. Preclinical hypothyroidism: A risk factor for coronary-heart disease. Lancet 1: 203, 1971.

    Article  PubMed  CAS  Google Scholar 

  6. Evered D.C., Ormston B.J., Smith P.A., Hall R., Bird T. Grades of hypothyroidism. Br. Med. J. 1: 657, 1973.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  7. Tunbridge W.M.G., Brewis M., French J.M., Appleton D., Bird T., Clark F., Evered D.C., Evans J.G., Hall R., Smith P., Stephenson J., Young E. Natural history of autoimmune thyroiditis. Br. Med. J. (Clin. Res.) 282: 258, 1981.

    Article  CAS  Google Scholar 

  8. Gordin A., Lamberg B-A. Spontaneous hypothyroidism in symptomless autoimmune thyroiditis: A long-term follow-up study. Clin. Endocrinol. (Oxf.) 15: 537, 1981.

    Article  CAS  Google Scholar 

  9. Tibaldi J., Barzel U.S. Thyroxine supplementation for the prevention of clinical hypothyroidism. Am. J. Med. 79: 241, 1985.

    Article  PubMed  CAS  Google Scholar 

  10. Sawin C.T., Chopra D., Azizi F., Mannix J.E., Bacharach P. The aging thyroid: Increased prevalence of elevated serum thyrotropin levels in the elderly. JAMA 242: 247, 1979.

    Article  PubMed  CAS  Google Scholar 

  11. Tunbridge W.M.G., Evered D.C., Hall R., Appleton D., Brewis M., Clark F., Evans J.G., Young E., Bird T., Smith P.A. The spectrum of thyroid disease in a community: The Wickham survey. Clin. Endocrinol. (Oxf.) 7: 481, 197

  12. Lipson A., Nickoloff E.L., Hsiung Has T., Kasecamp W.R., Drew H.M., Shakir R., Wagner H.N. Jr. A study of age-dependent changes in thyroid function tests in adults. J. Nucl. Med. 20: 1124, 1979.

    PubMed  CAS  Google Scholar 

  13. Rosenthal M.J., Sanchez C.J. Thyroid disease in the elderly-missed diagnosis or over diagnosis? West J. Med. 743: 643, 1985.

    Google Scholar 

  14. Bahemuka M., Hodkinson H.M. Screening for hypothyroidism in elderly inpatients. Br. Med. J. 2: 601, 1975.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  15. Atkinson R.L., Dahms W.T., Fisher DA, Nichols A.L Occult thyroid disease in an elderly hospitalized population. J. Gerontol. 33: 372, 1978.

    Article  PubMed  CAS  Google Scholar 

  16. Falkenberg M., Kagedal B., Norr A. Screening of an elderly female population for hypo-and hyperthyroidism by use of a thyroid hormone panel. Acta Med. Scand. 214: 361, 1983.

    Article  PubMed  CAS  Google Scholar 

  17. Rosenthal M.J., Hunt W.C., Garry P.J., Goodwin J.S. Thyroid failure in the elderly: Microsomal antibodies as discriminant for therapy. JAMA 258: 209, 1978.

    Article  Google Scholar 

  18. Rosenbaum R.L., Barzel U.S. Clinical hypothyroidism in the elderly. A preventable disorder? J. Am. Geriatr. Soc. 29: 221, 1981.

    PubMed  CAS  Google Scholar 

  19. Caren P.H., Calazel C, Parra HJ., Hoff M., Loavet J.P. Decreased HDL cholesterol in “subclinical hypothyroidism”: The effect of L-thyroxine therapy. Clin. Endocrinol. (Oxf.) 33: 519, 1990.

    Article  Google Scholar 

  20. Arem R., Patsch W. Lipoprotein and apolipoprotein levels in “subclinical hypothyroidism”. Effect of levothyroxine therapy. Arch. Intern. Med. 150: 2097, 1990.

    Article  PubMed  CAS  Google Scholar 

  21. Kung A.W.C., Pang R.W., Janus E.D. Elevated lipoprotein (a) in patients with subclinical hypothyroidism. Clin. Endocrinol. (Oxf.), 43: 445, 1995.

    Article  CAS  Google Scholar 

  22. Kabadi U.M. “Subclinical hypothyroidismn”: Natural course of the syndrome during a prolonged follow-up study. Arch. Intern. Med. 153: 957, 1993.

    Article  PubMed  CAS  Google Scholar 

  23. Kabadi U.M. Normal thyrotrophin response to intravenous thyrotrophin releasing hormone administration: The best index of optimal L-thyroxine therapy in primary hypothyroidism. Postgrad. Med. J. 61: 685, 1985.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  24. Kabadi U.M., Rosman P.M. Lack of influence of aging on hypothalamic pituitary thyroid axis in normal subjects. J. Clin. Exper. Gerontol., 9: 189, 1987.

    CAS  Google Scholar 

  25. Wartofsky L, Burman K. Alteration in thyroid function in patients with systemic illness: The “euthyroid sick syndrome”. Endocr. Rev. 3: 164, 1982.

    Article  PubMed  CAS  Google Scholar 

  26. Helfand M., Crapo L.M. Screening for thyroid disease. Ann. Intern. Med. 112: 840, 1990.

    Article  PubMed  CAS  Google Scholar 

  27. Parle J.V., Franklyn J.A., Cross K.W., Jones S.C., Sheppard M.C. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin. Endocrinol. (Oxf.) 34: 77, 1991.

    Article  CAS  Google Scholar 

  28. Wood J.M., Gordon D.L., Rudinger A.N., Brooks M.M. Artifactual elevation of thyroid-stimulating hormone. Am. J. Med. 90: 261, 1991.

    Article  PubMed  CAS  Google Scholar 

  29. Helfand M, Crapo L.M. Screening for thyroid disease. Ann. Intern. Med. 112: 840, 1990.

    Article  PubMed  CAS  Google Scholar 

  30. Kabadi U.M., Rosman P.M. Thyroid hormone indices in adult healthy subjects: No influence of aging. J. Am. Geriatr. Soc. 36: 312, 1988.

    PubMed  CAS  Google Scholar 

  31. Vanderpump M.P.J., Tunbridge W.M.G., French J.M., Appleton D., Bates D., Clarks F., Evans J.G., Hasan D.M., Rodgers H., Tunbridges F., Young E.T. The incidence of thyroid disorders in the community: A twenty-year follow-up of the Whickham Survey. Clin. Endocrinol. (Oxf.) 43: 55, 1995.

    Article  CAS  Google Scholar 

  32. Mandel S.J., Brent G.A., Larsen P.R. Levothyroxine therapy in patients with thyroid disease. Ann. Intern. Med. 119: 492, 1993.

    Article  PubMed  CAS  Google Scholar 

  33. Roti E., Minelli R., Gardini E., Braverman L.E. The use and misuse of thyroid hormone. Endocr. Rev. 14: 401, 1993.

    PubMed  CAS  Google Scholar 

  34. Baker B.A., Hossen G., Markowitz H. Correlation of thyroid antibodies and cytologic features in suspected autoimmune thyroid disease. Ann. J. Med. 74: 941, 1983.

    Article  CAS  Google Scholar 

  35. Wilson R., McKillop J.H., Crocket G.T., Pearson C, Jenkins C, Burns F., Burnett A.K., Thomson J.A. The effect of lithium therapy on parameters thought to be involved in the development of autoimmune thyroid disease. Clin. Endocrinol. (Oxf.), 34: 357, 1991.

    Article  CAS  Google Scholar 

  36. Peterson V.B., Mcgregor A.M., Belchetz P.E., Elkeles R.S., Hall R. The secretion of thyrotropin with impaired biological activity in patients with hypothalamic-pituitary disease. Clin. Endocrinol. (Oxf.) 8: 397, 1978.

    Article  Google Scholar 

  37. Faglia G., Bitensky L, Pinchera A., Ferrari C, Paracchi A., Beck-Peccoz P., Ambrosi B., Spada A. Thyrotropin secretion in patients with central hypothyroidism: Evidence for reduced biological activity of immunoreactive thyrotropin. J. Clin. Endocrinol. Metab. 6: 989, 1979.

    Article  Google Scholar 

  38. Beck-Peccoz P., Amr S., Menezes-Ferreira M., Faglia G., Weintraub B.D. Decreased receptor binding of biologically inactive thyrotropin in central hypothyroidism. N. Engl. J. Med. 312: 1085, 1985.

    Article  PubMed  CAS  Google Scholar 

  39. Horimoto M., Nishikawa M., Ishihara T., Yoshikawa N., Yoshimura M., Inada M. Bioactivity of thyrotropin (TSH) in patients with central hypothyroidism: Comparison between in vivo 3,5,3’-Triiodothyronine response to TSH and in vivo bioactivity of TSH. J. Clin. Endocrinol. Metab. 80: 1124, 1995.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

The data were presented in part at the annual meeting of the Endocrine Society — June 1991 in Washington D.C.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kabadi, U.M., Cech, R. Normal thyroxine and elevated thyrotropin concentrations: Evolving hypothyroidism or persistent euthyroidism with reset thyrostat. J Endocrinol Invest 20, 319–326 (1997). https://doi.org/10.1007/BF03350310

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03350310

Key-words

Navigation